Watertown, Massachusetts-based Zikani Therapeutics, a provider of a Turbo-ZM platform, has secured $7.5 million in Series A-1 financing. The investors were Advent Life Sciences, Gurnet Point Capital and Roche Venture Fund.
Source: Press Release
Zikani Therapeutics lands $7.5m
Watertown, Massachusetts-based Zikani Therapeutics, a provider of a Turbo-ZM platform, has secured $7.5 million in Series A-1 financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: